A recent study has shown that PLCG2 is a member of a network of co-expressed microglial genes, which is upregulated in brain regions affected by AD pathology, where its upregulation is either resulted from enhanced numbers or activation state of microglia or both (Conway et al., 2018). This evidence concerns the gene PLCG2 and Alzheimer disease.